The 5 Best-Performing Big Pharma Stocks of 2013: BMY, ABBV, RHHBY, JNJ, AZN
The pharmaceutical sector had a stellar 2013, but which stocks were the best?
Shorts Are Piling Into These Stocks. Should You Be Worried?
Do short-sellers have these stocks pegged? You be the judge!
Cancer Immunotherapy: The Breakthrough of 2013
With Roche, Merck, and Bristol-Myers Squibb posting impressive clinical trial results, immunotherapy represents a major breakthrough in treating cancer.
Will Seattle Genetics Have a Happy New Year?
This biopharma could be a big winner in the New Year.
Why You Should Watch Amgen and Inovio Today
These health-care stocks could be big winners today
What Does the ViroPharma Buyout Mean for BioMarin?
Orphan drugmakers are hot-ticket items in the biopharma industry.
The 5 Most Common Infectious Diseases
Infectious diseases affect billions of people around the globe annually. According to WHO and the CDC, these infectious diseases are the five most common.
Puma Biotechnology: The Best Performing Biotechs of 2013
Here's why Puma Biotechnology Inc. (NYSE: PBYI) rallied more than 350% this year.
Inovio Pharmaceuticals Inc: The Best Performing Biotechs of 2013
Here's why Inovio Pharmaceuticals Inc. (NYSEMKT: INVO) is up nearly 300% this year.